These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23408017)

  • 1. Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis?
    Catalá-López F; Sanfélix-Gimeno G; Tobías A; Hurtado I; Sanfélix-Genovés J; Peiró S
    Osteoporos Int; 2013 Jun; 24(6):1927-8. PubMed ID: 23408017
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to comments on: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.
    Freemantle N; Cooper C; Diez-Perez A; Gitlin M; Radcliffe H; Shepherd S; Roux C
    Osteoporos Int; 2013 Jun; 24(6):1931-2. PubMed ID: 23408019
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Freemantle et al.: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments.
    Brandi ML; Reginster JY; Rizzoli R; Cannata-Andia JB
    Osteoporos Int; 2013 Jun; 24(6):1929-30. PubMed ID: 23408018
    [No Abstract]   [Full Text] [Related]  

  • 4. Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.
    Reginster J-; Bianic F; Campbell R; Martin M; Williams SA; Fitzpatrick LA
    Osteoporos Int; 2019 Jul; 30(7):1465-1473. PubMed ID: 30953114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison table: some drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Jun; 59(1523):e104-e106. PubMed ID: 28609428
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):203-210. PubMed ID: 29232356
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison table: Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):e210-e212. PubMed ID: 29232357
    [No Abstract]   [Full Text] [Related]  

  • 8. Abaloparatide (Tymlos) for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Jun; 59(1523):97-98. PubMed ID: 28609423
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.
    Komm BS; Morgenstern D; A Yamamoto L; Jenkins SN
    Expert Rev Clin Pharmacol; 2015; 8(6):769-84. PubMed ID: 26482902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
    Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
    Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab for Reducing Risk of Fractures in Postmenopausal Women.
    Song P; Zehtabchi S
    Am Fam Physician; 2019 May; 99(9):Online. PubMed ID: 31038897
    [No Abstract]   [Full Text] [Related]  

  • 12. In postmenopausal women with osteoporosis, romosozumab followed by alendronate reduced fractures vs alendronate alone.
    Hirsch C
    Ann Intern Med; 2018 Jan; 168(2):JC3. PubMed ID: 29335715
    [No Abstract]   [Full Text] [Related]  

  • 13. Bones, heart and the new anabolic agent romosozumab.
    Pazianas M
    Postgrad Med J; 2019 Oct; 95(1128):521-523. PubMed ID: 31422376
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.
    Chen WC; Lin EY; Kang YN
    Osteoporos Int; 2019 Sep; 30(9):1723-1732. PubMed ID: 31041475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
    Barrionuevo P; Kapoor E; Asi N; Alahdab F; Mohammed K; Benkhadra K; Almasri J; Farah W; Sarigianni M; Muthusamy K; Al Nofal A; Haydour Q; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2019 May; 104(5):1623-1630. PubMed ID: 30907957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoporosis therapy. Drugs for strong bones].
    MMW Fortschr Med; 2013 Nov; 155(20):26. PubMed ID: 24482919
    [No Abstract]   [Full Text] [Related]  

  • 17. Denosumab (prolia) for treatment of postmenopausal osteoporosis.
    Johnson GL
    Am Fam Physician; 2012 Feb; 85(4):334-6. PubMed ID: 22335312
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison table: some drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2020 Jul; 62(1546):e112-e114. PubMed ID: 32728010
    [No Abstract]   [Full Text] [Related]  

  • 19. My mother was saved from hip fracture by treatment for osteoporosis, but will I be?--Implications on risk estimates from successful osteoporosis treatment.
    Rosengren BE; Karlsson MK
    Osteoporos Int; 2013 Feb; 24(2):739. PubMed ID: 22707066
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2020 Jul; 62(1602):105-112. PubMed ID: 32728009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.